2024 Seasonal influenza vaccines
Find out about the seasonal influenza vaccines available for the 2024 southern hemisphere season.
View ArticleACMD meeting statement, Meeting 77, 8 February 2024
Read the meeting statement from 8 February 2024 meeting of the Advisory Committee on Medical Devices (ACMD).
View ArticleNotice of interim decisions on proposed amendments to the Poisons Standard –...
Interim decisions and invitation for further comment. Closing date: 17 April 2024
View ArticleTherapeutic Goods Advertising and Compliance Education Plan 2024
This plan outlines the compliance and education priorities of the Therapeutic Goods Administration for 2024.
View ArticlePublic submissions on scheduling matters referred to the ACMS #43, ACCS #37...
Find out about the public submissions on interim decisions for scheduling matters referred to the ACMS #43, ACCS #37 and Joint ACMS-ACCS #35 meetings held in November 2023
View ArticlePoint-of-care Manufacturing of Medical Devices Steering Committee, Meeting...
A meeting statement from the first meeting of the Point-of-care Manufacturing of Medical Devices Steering Committee is now available.
View ArticleNotice of final decision to amend (or not amend) the current Poisons Standard...
Final decision on proposed amendments to the Poisons Standard relating to bromoxynil
View ArticlePoint-of-care Manufacturing of Medical Devices Dental Sector Working Group,...
A meeting statement from the Dental Sector Working Group is now available.
View ArticlePoint-of-care Manufacturing of Medical Devices Allied Health Sector Working...
A meeting statement from the Medical Devices Allied Health Sector Working Group is now available.
View ArticlePoint-of-care Manufacturing of Medical Devices Complex Manufacturing Hubs in...
A meeting statement from the Point-of-care Manufacturing of Medical Devices Complex Manufacturing Hubs in Healthcare Facilities Working Group is now available.
View ArticleMedical device reforms: Consumer Working Group meeting statement, Meeting 13,...
Read key points of discussion from the meeting 13 of the Medical Devices Consumer Working Group (MDCWG).
View ArticleACMD meeting statement, Meeting 78, 18 April 2024
Read the meeting statement from 18 April 2024 meeting of the Advisory Committee on Medical Devices (ACMD).
View ArticleNotice of final decision to amend (or not amend) the current Poisons Standard...
Read our notice of final decision to amend (or not amend) the current Poisons Standard
View ArticleAction Plan for Medical Devices - Progress Report Card: December 2023
The report cards show the progress made by the TGA in the 3 strategies that make up the Action Plan for Medical Devices.
View ArticleCosmetic injectables: import and supply in Australia
This fact sheet is for healthcare practitioners to help understand the rules surrounding importation of cosmetic injectables.
View ArticleNotice of decision to amend the current Poisons Standard in relation to nicotine
This publication is a notice of decision made by a delegate of the Secretary of the Department of Health and Aged Care under section 52D(2) of the Therapeutic Goods Act 1989, and the reasons for the...
View ArticleAustralia’s breast implant risk management framework
This framework outlines our processes to identify and manage risk relating to breast implants.
View ArticleACV meeting statement, meeting 48, 1 May 2024
Advisory Committee on Vaccines meeting statement for meeting 48 held on 1 May 2024.
View ArticleACV meeting statement, meeting 47, 31 January 2024
Advisory Committee on Vaccines meeting statement for meeting 47, held on 31 January 2024.
View ArticleTesting of medicinal cannabis products being supplied via SAS in Australia -...
Medicinal cannabis products are permitted to be supplied into Australia under the Special Access Scheme, by authorised prescribers, and/or for use in clinical trials.
View ArticleWomen’s Health Products Working Group meeting #6, 27 March 2024
Communique from the 6th meeting of the WHPWG, 27 March 2024
View ArticleCost Recovery Implementation Statement 2024-2025
This Cost Recovery Implementation Statement (CRIS) 2024-2025 provides information on how we implement, and cost recover our regulatory activities.
View ArticleACMD meeting statement, Meeting 79, 27 June 2024
Read the meeting statement from 27 June 2024 meeting of the Advisory Committee on Medical Devices (ACMD).
View ArticleACM meeting statement, Meeting 44, 4 and 5 April 2024
Advisory Committee on Medicines meeting statement
View ArticleDocuments released under Section 11C of the Freedom of Information Act 1982,...
Documents released under the FOI Act in the 2023/24 financial year
View ArticlePublic submissions on scheduling matters referred to the ACMS #44, ACCS #38...
Find out about the public submissions on scheduling matters referred to the ACMS #44, ACCS #38 and Joint ACMS-ACCS #36 meetings held in March 2024
View ArticleNotice of interim decisions on proposed amendments to the Poisons Standard –...
Interim decisions and invitation for further comment. Closing date: 23 August 2024
View ArticleACM meeting statement, Meeting 45, 6 and 7 June 2024
Advisory Committee on Medicines meeting statement
View ArticleMedicine Shortages Report 2024
Find out how we are managing shortages of medicines and taking action to limit their effects. Read our 2024 report.
View ArticleTGA business plan 2024-25
Read our business plan 2024-25 to find out about our strategic priorities and activities.
View ArticleACMD meeting statement, Meeting 80, 8 August 2024
The 80th meeting of the Advisory Committee on Medical Devices (ACMD), 8 August 2024.
View ArticleMedical device reforms: Consumer Working Group meeting statement, Meeting 14,...
Read key points of discussion from the meeting 14 of the Medical Devices Consumer Working Group (MDCWG).
View ArticleWomen’s Health Products Working Group meeting #7, 30 July 2024
Communique from the 7th meeting of the WHPWG 30 July 2024
View ArticleNotice of final decision on proposed amendment to the Poisons Standard in...
This publication is a notice of decision made by a delegate of the Secretary of the Department of Health and Aged Care under regulation 42ZCZX of the Therapeutic Goods Regulations 1990, and the reasons...
View ArticleNotice of interim decisions on proposed amendments to the Poisons Standard –...
Interim decisions on proposed amendments to the Poisons Standard closing 18 October 2024.
View ArticleFinal decisions to amend the current Poisons Standard in relation to...
Publication of the decisions made by a delegate of the Secretary in relation to glycopyrronium and palmitoylethanolamide.
View ArticleNotice of final decision to amend (or not amend) the current Poisons Standard...
This web publication constitutes a notice for the purposes of regulations 42ZCZS and 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations).
View ArticlePublic submissions on interim decisions for scheduling matters referred to...
Find out about the public submissions on interim decisions for scheduling matters referred to the ACMS #44, ACCS #38 and Joint ACMS-ACCS #36 meetings held in March 2024
View ArticleAIVC Recommendations for the Composition of Influenza Vaccines for Australia...
Find out about the AIVC Recommendations for the Composition of Influenza Vaccines for Australia in 2025.
View ArticlePoint-of-care Manufacturing of Medical Devices Steering Committee, Meeting...
A meeting statement from the second meeting of the Point-of-care Manufacturing of Medical Devices Steering Committee is now available.
View ArticleACMD meeting statement, Meeting 81, 10 October 2024
Read the meeting statement from 10 October 2024 meeting of the Advisory Committee on Medical Devices
View ArticleACM meeting statement, Meeting 46, 1 and 2 August 2024
Advisory Committee on Medicines meeting statement
View ArticleMarket research - Understanding the impact of medicine shortages in Australia
We commissioned the Health Design Lab to conduct market research to better understand the individual consumer, pharmacist and prescriber experiences of shortages and discontinuations.
View ArticleTherapeutic Goods Advertising Consultative Committee, 20 September 2024
Communique from the meeting of the TGACC
View ArticleSummary report of residual DNA and endotoxin on CoVID-19 mRNA vaccines...
The TGA has conducted a comprehensive evaluation of the residual DNA and endotoxin levels in the two mRNA vaccines supplied in Australia - Comirnaty (Pfizer) and Spikevax (Moderna).
View ArticleTGA stakeholder survey report 2024
Read our 2024 stakeholder survey report, which aims to improve the way we work with our stakeholders.
View ArticleACM meeting statement, Meeting 47, 3 and 4 October 2024
Advisory Committee on Medicines meeting statement
View ArticleNotice and invitation to comment on interim decisions to amend the current...
We are seeking submissions for a consultation on the interim decisions for IV potassium salts and nicotinic acid.
View ArticleNotice of final decision to amend (or not amend) the current Poisons Standard...
This web publication constitutes a notice for the purposes of regulations 42ZCZS and 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations).
View ArticleACCM meeting statement, Meeting 34, 14 March 2024
Advisory Committee on Complementary Medicines meeting statement for 14 March 2024
View Article